Theriva Biologics, Inc.

Theriva Biologics, Inc. annual/quarterly operating income history and growth rate from to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.

• Theriva Biologics, Inc. operating income for the quarter ending March 31, 2026 was -2.1 M.
• Theriva Biologics, Inc. operating income for the twelve months ending March 31, 2026 was -4.7 M.